Table 3 Estimated crude and adjusted odds ratios for the overweight/obesity, underweight, high Tg, high Chol. and low HDL in Offspring, as predicted by paternal exposure to opioid.
From: Cohort-based analysis of paternal opioid use in relation to offspring’s BMI and plasma lipid profile
Crude model | Adjusted model 1 | Adjusted model 2 | Adjusted model 3 | |||||
|---|---|---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Father regular opioid use (all routs of administration) | ||||||||
Overweight/obesity** | ||||||||
Before child birth | 1.01 (0.68–1.50) | 0.933 | 1.28 (0.82–1.99) | 0.272a | 1.48 (0.92–2.36) | 0.101b | 1.51 (0.94–2.42) | 0.084c |
After child birth | 1.16 (0.82–1.64) | 0.386 | 1.52 (1.01–2.27) | 0.041a | 1.72 (1.12–2.65) | 0.012b | 1.76 (1.15–2.71) | 0.009c |
Underweight* | ||||||||
Before child birth | 0.80 (0.48–1.33) | 0.399 | 0.56 (0.31–1.00) | 0.050a | 0.45 (0.24–0.84) | 0.012b | 0.46 (0.25–0.86) | 0.015c |
After child birth | 1.03 (0.67–1.59) | 0.880 | 0.79 (0.48–1.30) | 0.362a | 0.65 (0.38–1.11) | 0.121b | 0.66 (0.38–1.13) | 0.134c |
Tg > 150 | ||||||||
Before child birth | 1.27 (0.83–1.93) | 0.261 | 1.32 (0.83–2.08) | 0.227d | 1.32 (0.82–2.15) | 0.245e | 1.28 (0.79–2.09) | 0.302f. |
After child birth | 1.40 (0.96–2.05) | 0.073 | 1.36 (0.90–2.06) | 0.137d | 1.37 (0.88–2.11) | 0.155e | 1.33 (0.86–2.06) | 0.194f. |
Chol > 200 | ||||||||
Before child birth | 1.03 (0.54–1.95) | 0.914 | 1.01 (0.51–2.03) | 0.958 g | 0.90 (0.44–1.84) | 0.780 h | 0.89 (0.43–1.83) | 0.755i |
After child birth | 1.44 (0.85–2.44) | 0.166 | 1.31 (0.74–2.32 | 0.346 g | 1.16 (0.64–2.13) | 0.609 h | 1.15 (0.63–2.11) | 0.634i |
HDL < 40 | ||||||||
Before child birth | 1.25 (0.81–1.94) | 0.301 | 1.22 (0.73–2.05) | 0.438j | 1.36 (0.78–2.37) | 0.273 k | 1.34 (0.76–2.33) | 0.302 l |
After child birth | 0.85 (0.55–1.31) | 0.479 | 0.84 (0.51–2.05) | 0.506j | 0.92 (0.54–1.57) | 0.775 k | 0.91 (0.53–1.55) | 0.744 l |
Father regular opioid inhaling | ||||||||
Overweight/obesity** | ||||||||
Before child birth | 1.06 (0.71–1.58) | 0.753 | 1.34 (0.85–2.11) | 0.197a | 1.56 (0.96–2.53) | 0.066b | 1.60 (0.99–2.59) | 0.055c |
After child birth | 1.19 (0.84–1.70) | 0.318 | 1.47 (0.98–2.23) | 0.061a | 1.69 (1.09–2.61) | 0.017b | 1.73 (1.12–2.68) | 0.014c |
Underweight* | ||||||||
Before child birth | 0.73 (0.43–1.26) | 0.268 | 0.49 (0.26–0.91) | 0.026a | 0.40 (0.21–0.77) | 0.006b | 0.41 (0.21–0.78) | 0.007c |
After child birth | 1.11 (0.72–1.71) | 0.628 | 0.89 (0.54–1.48) | 0.675a | 0.74 (0.43–1.27) | 0.277b | 0.74 (0.43–1.28) | 0.286c |
Father regular opioid inhaling Sensitivity analysis (by young adult sex) | ||||||||
Sons | ||||||||
Overweight/obesity** | ||||||||
Before child birth | 1.36 (0.82–2.27) | 0.227 | 1.83 (1.01–3.31) | 0.044 m | 2.27 (1.20–4.31) | 0.012n | 2.41 (1.26–4.58) | 0.007o |
After child birth | 1.80 (1.14–2.83) | 0.011 | 2.36 (1.38–4.02) | 0.002 m | 2.85 (1.60–5.06) | 0.000n | 3.01 (1.68–5.39) | 0.000o |
Underweight* | ||||||||
Before child birth | 0.84 (0.40–1.79) | 0.666 | 0.55 (0.23–1.33) | 0.191 m | 0.40 (0.15–1.04) | 0.062n | 0.40 (0.15–1.04) | 0.061o |
After child birth | 1.29 (0.70–2.38) | 0.397 | 1.47 (0.72–2.98) | 0.285 m | 1.11 (0.51–2.40) | 0.776n | 1.11 (0.51–2.39) | 0.781o |
Daughters | ||||||||
Overweight/obesity** | ||||||||
Before child birth | 0.70 (0.36–1.36) | 0.299 | 0.93 (0.45–1.94) | 0.862 m | 1.02 (0.47–2.19) | 0.948n | 1.02 (0.47–2.19) | 0.955o |
After child birth | 0.59 (0.32–1.10) | 0.099 | 0.68 (0.34–1.38) | 0.290 m | 0.74 (0.36–1.55) | 0.436n | 0.74 (0.35–1.54) | 0.431o |
Underweight* | ||||||||
Before child birth | 0.66 (0.30–1.44) | 0.299 | 0.46 (0.19–1.10) | 0.083 m | 0.39 (0.15–0.98) | 0.046n | 0.43 (0.17–1.10) | 0.081o |
After child birth | 0.97 (0.52–1.82) | 0.939 | 0.61 (0.29–1.27) | 0.191 m | 0.52 (0.24–1.15) | 0.108n | 0.53 (0.24–1.17) | 0.117o |